Chlorpromazine Absorption From a New Tablet Formulation

Study information

Recruitment status

Completed

Enrollment listed in the registry

20

Sponsor

Cycle Pharmaceuticals Ltd.

Sponsor type

Other organization

Study type

Drug

Intervention type

Medication / drug

Study phase

Phase 1iUsually an early study focused on safety, tolerability, dosage, and side effects.

Locations

South Africa

Age range

From 18 Years to 65 Years

Official registry ID

NCT02943213

Official title

Show the full official title

A Single Center, Single Dose, Open-Label, Two-Period Replicate Pilot Study to Investigate Intra-subject Variability in the Bioavailability of a Formulation Containing Chlorpromazine Hydrochloride (25 mg Sugar Coated Tablets) in at Least 16 Healthy Males and Females Under Fasting Conditions